Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations
that may prevail in the form of venous or arterial thrombosis or lead to pregnancy …

Persistence of serum antiphospholipid antibodies (aPL) is associated with a high thrombotic
risk, both arterial and venous, and with pregnancy complications. Due to the potential …

Background Antiphospholipid syndrome (APS) is characterized by the presence of
circulating antiphospholipid antibodies (aPL) in patients with thrombosis and/or pregnancy …

Background Patients with antiphospholipid syndrome (APS) often have thrombotic
recurrences, sometimes despite appropriate ongoing anticoagulant treatment. Identifying …

Antiphospholipid syndrome (APS) is characterized by recurrent arterial/venous thrombosis
and miscarriages in the persistent presence of autoantibodies against phospholipid-binding …

Thrombotic antiphospholipid syndrome (TAPS) is characterized by thrombosis and
persistently positive tests for antiphospholipid antibodies or lupus anticoagulant (LAC) …

Antiphospholipid syndrome (APS) is an acquired hypercoagulable state necessitating long-
term anticoagulation for secondary thrombosis prevention. Anticoagulation guidelines are …

Antiphospholipid antibodies (aPL) represent a group of autoantibodies directed against
phospholipids. These antibodies may arise in a number of autoimmune conditions, of which …

Hemostasis Awards” in honor of Eberhard Mammen (► Fig. 1) and in recognition of his
contribution to this field and to the journal that he founded and steered for over three …

Mammen (► Fig. 1), and in recognition of his contribution to this field and to the journal that
he both founded and steered for over three decades (see► Table 1 for relevant references) …